13F filer · CIK 1335325
HighVista Strategies LLC
BOSTON, MA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$438.6M
+$76.4M vs prior
Positions
147
New / sold out
29 / 38
Added / reduced
50 / 66
Turnover
24.2%
buys $99.1M · sells $96.9M
Top-10 weight
28.2%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | C4 THERAPEUTICS INC | +1,348,136 | – | +$6.3M |
| Added | ALKERMES PLC | +106,067 | +144.9% | +$5.6M |
| Added | TANGO THERAPEUTICS INC | +155,877 | +149.6% | +$4.9M |
| Added | ENLIVEN THERAPEUTICS INC | +64,764 | +88.6% | +$3.3M |
| New | RELMADA THERAPEUTICS INC | +445,799 | – | +$3.1M |
| Added | TRAVERE THERAPEUTICS INC | +49,908 | +137.4% | +$2.8M |
| Added | DEFINIUM THERAPEUTICS INC | +57,028 | +30.7% | +$2.7M |
| Added | ALUMIS INC | +87,039 | +77.1% | +$2.4M |
| Added | TARSUS PHARMACEUTICALS INC | +34,596 | +65.9% | +$2.2M |
| Added | PHARVARIS N V | +62,628 | +64.0% | +$2.2M |
69 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SPYRE THERAPEUTICS INC | -68,457 | -46.8% | $-6.1M |
| Sold out | TERNS PHARMACEUTICALS INC | -114,307 | -100.0% | $-6.0M |
| Sold out | NUVALENT INC | -56,602 | -100.0% | $-5.8M |
| Sold out | SOLENO THERAPEUTICS INC | -165,227 | -100.0% | $-5.5M |
| Reduced | ORUKA THERAPEUTICS INC | -37,009 | -46.9% | $-3.5M |
| Sold out | APOGEE THERAPEUTICS INC | -35,761 | -100.0% | $-3.0M |
| Reduced | MICRON TECHNOLOGY INC | -2,540 | -66.8% | $-2.9M |
| Reduced | BRIDGEBIO PHARMA INC | -36,404 | -73.5% | $-2.7M |
| Reduced | AMAZON COM INC | -9,000 | -40.2% | $-2.1M |
| Sold out | JAZZ PHARMACEUTICALS PLC | -10,838 | -100.0% | $-2.0M |
94 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | INVESCO DB COMMDY INDX TRCKUNIT | 1,057,238 | $28.2M | 6.43% |
| 2 | ABIVAX SASPONSORED ADS | 113,031 | $15.1M | 3.43% |
| 3 | REVOLUTION MEDICINES INCCOM | 66,983 | $12.5M | 2.86% |
| 4 | DEFINIUM THERAPEUTICS INCCOM SHS | 242,884 | $11.4M | 2.60% |
| 5 | IMMUNOVANT INCCOM | 277,873 | $10.7M | 2.44% |
| 6 | PRAXIS PRECISION MEDICINES ICOM NEW | 30,210 | $10.1M | 2.31% |
| 7 | RELAY THERAPEUTICS INCCOM | 506,235 | $9.5M | 2.16% |
| 8 | ALKERMES PLCSHS | 179,256 | $9.4M | 2.14% |
| 9 | VAXCYTE INCCOM | 149,739 | $8.7M | 1.98% |
| 10 | TANGO THERAPEUTICS INCCOM | 260,070 | $8.1M | 1.85% |
137 more rows. Subscribe for $29/month to see every row, download the data and use the API.